Taking our previous work regarding the role of MΦ as cellular source of iron within the TME [12,13] and the role of both FPN and Lcn-2 in determining the MΦ iron-release phenotype into account, we aimed at clarifying the role of stromal FPN and Lcn-2 for tumor progression. The gene discussed is LCN2; the disease is neoplasm.